← k3vl4r
Log inGet started →

PALI (Palisade Bio Inc) Price Forecast

AI-generated price forecast for Palisade Bio Inc (PALI) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads PALI as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 1.54. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

1.54

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

PALI forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+23.51%
Weekly——

Calibrated: each horizon's forecast is weighted by how often the model has called PALI's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest PALI news

From the market-news feed the forecasts are read against.

  • HC Wainwright & Co. Reiterates Buy on Palisade Bio, Maintains $7 Price Target · Benzinga · Oct 13
  • Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026 · Yahoo · Oct 12
  • Palisade Bio Highlights PALI-2108 Clinical And Translational Findings In 5 ACG 2026 Presentations · Benzinga · Oct 12
  • Raymond James Initiates Coverage On Palisade Bio with Outperform Rating, Announces Price Target of $6 · Benzinga · Oct 9
  • Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026 · Yahoo · Sep 28

🔒

See the full PALI forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PALI forecast — frequently asked

Will PALI go up?

K3vl4r's calibrated AI forecast currently reads PALI as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PALI price prediction for 2026?

K3vl4r's model projects PALI toward $1.90 over the next ~4 weeks, a +23.5% move from $1.54. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

LGVNCGEMPHATSNDALXRXSLSCDXSCOOBKDIRONEHCSENSIPSCCTXR

Will PALI reach…?

Will PALI reach $2.00?Will PALI reach $3.00?Will PALI reach $5.00?Will PALI reach $10.00?

Or see the full PALI price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PALI

PALI vs LGVNPALI vs CGEMPALI vs PHATPALI vs SNDAPALI vs LXRXPALI vs SLS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.